TFF3

Chr 21

trefoil factor 3

Also known as: ITF, P1B, TFI

TFF3 encodes trefoil factor 3, a secretory protein expressed in intestinal goblet cells that maintains and repairs intestinal mucosa by promoting epithelial cell mobility during healing processes. Mutations cause congenital diarrhea with intestinal atresias, malrotations, and dysmotility following autosomal recessive inheritance. The gene shows low constraint to loss-of-function variation, consistent with recessive disease requiring biallelic mutations.

Summary from RefSeq, UniProt
Research Assistant →
1
Active trials
73
Pubs (1 yr)
88
P/LP submissions
0%
P/LP missense
1.59
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryTFF3
Population Constraint (gnomAD)
Low constraint (pLI 0.02) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
83 unique Pathogenic / Likely Pathogenic· 14 VUS of 100 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.59LOEUF
pLI 0.016
Z-score 0.69
OE 0.65 (0.291.59)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.51Z-score
OE missense 0.80 (0.631.03)
44 obs / 54.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.65 (0.291.59)
00.351.4
Missense OE0.80 (0.631.03)
00.61.4
Synonymous OE1.02
01.21.6
LoF obs/exp: 3 / 4.6Missense obs/exp: 44 / 54.7Syn Z: -0.10
DN
0.6938th %ile
GOF
0.79top 25%
LOF
0.1498th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic80
Likely Pathogenic3
VUS14
Likely Benign1
Benign1
Conflicting1
80
Pathogenic
3
Likely Pathogenic
14
VUS
1
Likely Benign
1
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
80
0
80
Likely Pathogenic
0
0
3
0
3
VUS
0
6
8
0
14
Likely Benign
0
0
1
0
1
Benign
0
1
0
0
1
Conflicting
1
Total07920100

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TFF3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Literature
Open Research Assistant →